The present Competitive
Intelligence Report about peptide therapeutics provides a competitor evaluation
in the field of marketed and new molecules for treatment of inflammatory and
autoimmune diseases as of September 2014. Anti-Inflammatory peptides under development
and on the market are used for treatment of diseases ranging from psoriasis,
multiple sclerosis, transplantation and autoimmune diseases. Purchase of the
downloadable pdf report includes a 6-month online access to the data of the
report and any updates since the publication date. Credentials to access the
database will be sent by e-mail and allow online work with the project data to
print or export an individual report.
The report includes a compilation
of currently marketed and active projects in research and development of
anti-inflammatory peptides. In addition, the report lists company-specific
R&D pipelines of anti-inflammatory peptides.
Competitor projects are listed
in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Competitor Analysis Series:
The Competitor Analysis Series
delivers NO-FRILLS, but concise information about the pipeline of R&D
projects for targets, diseases, technologies and companies at low prices. The
information is provided in a tabular format and fully referenced.
Spanning over 44 pages “Competitor Analysis: Anti-Inflammatory Peptides” report covering 2013
Sales of Major Anti-Inflammatory Peptides, Cardiovascular Diseases,
Dermatological Diseases, Gastrointestinal
Diseases, Neurological Diseases, Ophthalmological & Otorhino Diseases,
Pulmonary & Respiratory Diseases, Renal Diseases, Rheumatological &
Autoimmune Diseases, Transplantation, Not-Specified Inflammatory &
Autoimmune Diseases, Corporate Anti-Inflammatory Peptide R&D Pipelines.
Know more
about this report at – http://mrr.cm/Zjr
Find all Biotechnology Reports
at: http://www.marketresearchreports.com/biotechnology
No comments:
Post a Comment
Note: only a member of this blog may post a comment.